Lupin rises as its Japanese arm plans to set up manufacturing plant in Japan

01 Mar 2016 Evaluate

Lupin is currently trading at Rs. 1768.25, up by 16.10 points or 0.92% from its previous closing of Rs. 1752.15 on the BSE.

The scrip opened at Rs. 1760.00 and has touched a high and low of Rs. 1772.25 and Rs. 1735.25 respectively. So far 14974 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127.00 on 06-Oct-2015 and a 52 week low of Rs. 1589.40 on 14-May-2015.

Last one week high and low of the scrip stood at Rs. 1798.00 and Rs. 1694.10 respectively. The current market cap of the company is Rs. 79343.36 crore.

The promoters holding in the company stood at 46.53% while Institutions and Non-Institutions held 43.56% and 9.92% respectively.

Lupin’s wholly-owned Japanese subsidiary -- Kyowa Pharmaceutical Industry, is planning to set up a manufacturing plant at Tottori, Japan as part of expansion plans in the country. In order to meet the rapidly growing demand of generics, the company is planning to set-up two billion tablets capacity plant at Tottori, Japan which would be designed to efficiently handle mass volume products and provide flexibility in allowing easy future expansion.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally.

 

Lupin Share Price

2102.60 12.95 (0.62%)
17-Dec-2025 11:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.90
Dr. Reddys Lab 1270.15
Cipla 1493.40
Zydus Lifesciences 915.40
Lupin 2102.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×